Momentum
Previous Close | 16.83 |
Open | 16.64 |
Bid | 16.20 x 1000 |
Ask | 17.20 x 900 |
Day's Range | 16.40 - 16.99 |
52 Week Range | 13.21 - 54.04 |
Volume | |
Avg. Volume | 851,535 |
Market Cap | 330.063M |
Beta (5Y Monthly) | 1.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BRISBANE, Calif., May 15, 2023--CUTERA, INC. ("Cutera" or the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that it has cancelled the Special Meeting of Stockholders previously scheduled for June 9, 2023 (the "Special Meeting"). The cancellation of the Special Meeting follows the withdrawals by former Chairman of the Board of Directors J. Daniel Plants and former Chief Executive Officer David H. Mowry of their respective demands to hold a s
BRISBANE, Calif., May 12, 2023--CUTERA, INC. ("Cutera" or the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today commented on the termination of the proxy solicitation by Voce Capital Management LLC ("Voce Capital") with respect to the Special Meeting of Stockholders, scheduled for June 9, 2023 (the "Special Meeting").
SAN FRANCISCO, May 11, 2023--Voce Capital Management LLC ("Voce"), owner of approximately 6.1% of the outstanding shares of Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), provided the following update on its intentions regarding Cutera’s special meeting of shareholders (the "Special Meeting"), scheduled for June 9, 2023.
BRISBANE, Calif., May 09, 2023--CUTERA, INC. ("Cutera" or the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that it has entered into cooperation agreements (the "Agreements") with two of its largest stockholders, Pura Vida Investments, LLC ("Pura Vida") and RTW Investments, LP ("RTW"), which collectively own more than 15% of the Company’s outstanding shares. Pursuant to the Agreements, the Company will appoint Kevin J. Cameron, Taylor C. Ha
BRISBANE, Calif., May 09, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2023.
BRISBANE, Calif., April 25, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter of 2023 after the market close on Tuesday, May 9, 2023.
SAN FRANCISCO, April 18, 2023--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and a member of the Board of Directors (the "Board") of Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), and David Mowry, also a Cutera Director – who together own approximately 7.0% of the outstanding shares of Cutera – issued the following statement in response to a recent press release from the Special Committee of Cutera’s Board:
BRISBANE, Calif., April 17, 2023--The Special Committee of the Board of Directors (the "Special Committee") of CUTERA, INC. (the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today issued an open letter to stockholders.
BRISBANE, Calif., April 14, 2023--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, is honored to announce that this year marks the monumental 25th anniversary for the company as an industry leader and innovator.
BRISBANE, Calif., April 13, 2023--CUTERA, INC. (the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced it will hold a Special Meeting of Stockholders ("Special Meeting") on June 9, 2023, at 9:00 am PT in or near Brisbane, California for the purpose of considering proposals offered by J. Daniel Plants and David Mowry to remove, without cause, five of the six directors who were independent at the time of receiving the notices (the "Targeted Direct
RTW Investments, LP ("RTW"), which manages funds holding approximately 9.3% of the outstanding shares of Cutera, Inc. (the "Company") (Nasdaq: CUTR), today announced that it was in favor of the Company holding the previously-called Special Meeting of Stockholders (the "Special Meeting") for the purpose of reconstituting the Board of Directors (the "Board") of the Company. RTW is concerned about the events that have transpired at the Company this past week, particularly with respect to the Board'
SAN FRANCISCO, April 12, 2023--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and a member of the Board of Directors (the "Board") of Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), and David Mowry, also a Cutera Director – who together own approximately 7.0% of the outstanding shares of Cutera – announced that they have filed a lawsuit in the Court of Chancery of the State of Delaware (the "Court") against Directors Gregory Barrett, Sheila H
BRISBANE, Calif., April 12, 2023--CUTERA, INC. (the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced significant changes to the Company’s executive leadership to focus on improving performance and results. The Board of Directors (the "Board") has appointed Sheila A. Hopkins as Interim Chief Executive Officer ("CEO") and Janet D. Widmann as Independent Chair of the Board, effective immediately. The Board’s search for a permanent CEO is underway
SAN FRANCISCO, April 11, 2023--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and Executive Chairman of the Board of Directors (the "Board") of Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), and David Mowry, Cutera’s Chief Executive Officer and a Director – who together own approximately 7.0% of the outstanding shares of Cutera – shared a letter of support from Cutera senior employees that has been sent to the Company’s Board.
NEW YORK, April 11, 2023--Pura Vida Investments, LLC ("Pura Vida"), a Delaware limited liability company with beneficial ownership of approximately 7% of the common stock of Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), today issued the following statement following the public turmoil amongst Cutera’s Board of Directors (the "Board").
BRISBANE, Calif., April 10, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that based on the Company’s April 7, 2023 filing of its Form 10-K for the period ended December 31, 2022 ("Form 10-K"), Nasdaq has determined that the Company is now in compliance with the periodic filing req
SAN FRANCISCO, April 10, 2023--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and Executive Chairman of the Board of Directors (the "Board") of Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), and David Mowry, Cutera’s Chief Executive Officer and a Director – who together own approximately 7.0% of the outstanding shares of Cutera – commented on the fact that they have each delivered to the Company separate notices (each, a "Notice") calling fo
BRISBANE, Calif., April 07, 2023--CUTERA, INC. (the "Company") (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today acknowledged receipt of, and issued the following response to, a demand by J. Daniel Plants to call a special meeting of stockholders.
BRISBANE, Calif., March 24, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on March 21, 2023 indicating that the Company is not currently in compliance with Nasdaq’s Listing Rules (the "Listing Rules") due to the Company’s inability to timely file its Form 10-K for the year ended De
BRISBANE, Calif., March 14, 2023--CUTERA, INC. (Nasdaq: CUTR) a leading provider of aesthetic and dermatology solutions, is proud to reveal the refreshed truBody brand. This award-winning treatment pairs two clinically proven technologies for a customized, convenient, and complete approach to fat reduction and muscle toning with 15-minute treatment options.
BRISBANE, Calif., February 28, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2022.
BRISBANE, Calif., February 15, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year of 2022 after the market close on Tuesday, February 28, 2023.
BRISBANE, Calif., January 09, 2023--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31, 2022. These results are subject to the completion of the Company’s year-end financial reporting processes, reviews, and audit.
BRISBANE, Calif., December 08, 2022--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced the pricing of $100 million aggregate principal amount of 4.00% convertible senior notes due 2029 (the "notes") in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Cutera also granted the initial purch
BRISBANE, Calif, December 07, 2022--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it intends to offer, subject to market conditions and other factors, $100 million aggregate principal amount of convertible senior notes due 2029 (the "notes") in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Sec